UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 162

of '化疗药物的肠道毒性'

162
TI
Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117).
AU
Fiorentini G, Rossi S, Lanzanova G, Bernardeschi P, Dentico P, De Giorgi U
SO
Ann Oncol. 2003;14(5):805.
 
AD
PMID